Study #PA18-0791
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study assesses neurocognitive outcomes after receiving radiation therapy to the brain (whole brain radiation therapy) in patients with blood cancers (hematologic malignancies). This may help researchers learn more about the effects of whole brain radiation therapy on memory and thinking in patients with blood cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Central Nervous System Lymphoma;Hematopoietic and Lymphoid Cell Neoplasm;Leukemia;Lymphoma;Plasma Cell Myeloma;Secondary Central Nervous System Lymphoma
Study phase:
Physician name:
Bouthaina Dabaja
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.